/HSTC
HSTC Stock - HST Global, Inc.
Healthcare|BiotechnologyOTC
$0.99+0.00%
+$0.00 (+0.00%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.09
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HSTC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.98 – $1.00
TARGET (TP)$1.14
STOP LOSS$0.91
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.24
52W High$1.05
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-38,055 | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-210,658 | $-141,000 | $-141,000 | $-146,000 | $-208,000 |
| Net Income | $-212,624 | $-146,000 | $-145,000 | $-148,000 | $-209,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.03 | $-0.03 | $-0.03 | $-0.04 |
Company Overview
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HSTCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 15, 2025 | — | $-0.00 | — | — |
Q3 2024 | Aug 26, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 5, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.01 | — | — |
Q4 2023 | Nov 6, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 11, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 4, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 26, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q4 2021 | Nov 8, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.02 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Nov 19, 2019 | — | $0.15 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HSTC
What is HSTC's current stock price?
HST Global, Inc. (HSTC) is currently trading at $0.99 per share. The stock has moved +0.00% today.
What is the analyst price target for HSTC?
No analyst price targets are currently available for this stock.
What sector is HST Global, Inc. in?
HST Global, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is HSTC's market cap?
HST Global, Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does HSTC pay dividends?
No, HST Global, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARDS
Aridis Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
BTAX
Biostax Corp.
$0.00
Mkt Cap: $0.0B
EVLO
Evelo Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
GSRX
GSRX Industries Inc.
$0.00
Mkt Cap: $0.0B
INFIQ
Infinity Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
LIFS
Life Stem Genetics Inc.
$0.00
Mkt Cap: $0.0B
ONPH
Oncology Pharma Inc.
$0.01
Mkt Cap: $0.0B
SCPX
Scorpius Holdings, Inc.
$0.00
Mkt Cap: $0.0B
STAB
Statera Biopharma, Inc.
$0.00
Mkt Cap: $0.0B
TRVN
Trevena, Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to HSTC for comparison